Marc Delcourt

This inventor holds 15 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 8 EPO patents. Top assignees: Global Bioenergies, Scientist of Fortune, S.a., Biomethodes. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc Delcourt. Retrieved from https://idiyas.com/inventor/marc-delcourt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 3)

% Patents Active = 53.3

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 10(Granted Patents)

Location History:

Villejuif, FR (2007)
Paris, FR (2005 - 2022)

Company Filing History:

Scientist of Fortune, S.a.

Global Bioenergies Sa

patent

6. 1 out of 46

Hospices Civils De Lyon

where one patent can have more than one assignee

Years Active: 2005-2026

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12624372 - IMPROVED MEANS AND METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID (2026-05-12),

2. 11261438 - Mevalonate diphosphate decarboxylase variants (2022-03-01),

3. 10407669 - HIV kinase variants (2019-09-10),

4. 10364418 - 3-hydroxyisovalerate (HIV) synthase variants (2019-07-30),

5. 10113186 - Alkenol dehydratase variants (2018-10-30),

6. 10036003 - Alkenol dehydratase variants of linalool dehydratase-isomerase (2018-07-31),

7. 9903873 - Method for selecting stable proteins in non-standard physicochemical conditions (2018-02-27),

8. 9879286 - Method for the enzymatic production of isoprenol using mevalonate as a substrate (2018-01-30),

9. 9752163 - Process for the production of isoprenol from mevalonate employing a diphosphomevalonate decarboxylase (2017-09-05),

10. 9193978 - Production of alkenes by combined enzymatic conversion of 3-hydroxyalkanoic acids (2015-11-24),

11. 9109210 - Enhanced phytase variants (2015-08-18),

12. 9102952 - Process for the production of isoprenol from mevalonate employing a diphospho-mevolonate decarboxylase (2015-08-11),

13. 8623824 - VIII factors for the treatment of type A hemophilia (2014-01-07),

14. 7202086 - Method for massive directed mutagenesis (2007-04-10),

15. 6924112 - Cloning method by multiple-digestion, vectors for implementing same and applications (2005-08-02),

Title: The Innovations of Marc Delcourt

Introduction

Marc Delcourt is a prominent inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of enzymes and their applications in producing valuable chemical compounds. With a total of 14 patents to his name, Delcourt's work has garnered attention for its potential impact on sustainable production processes.

Latest Patents

Delcourt's latest patents include innovative variants of mevalonate diphosphate decarboxylase. These variants exhibit improved activity in converting 3-phosphonoxyisovalerate into isobutene. This advancement can facilitate the biological production of isobutene from 3-hydroxyisovalerate or 3-hydroxy-3-methylbutyrate. Additionally, his patents describe an enzyme capable of converting 3-phosphonoxyisovalerate into isobutene with a kcat of more than 0.1 s. Another notable patent involves HIV kinase variants that show enhanced activity in converting 3-hydroxyisovalerate into 3-phosphonoxyisovalerate. These innovations also include methods for producing isobutene in subsequent reactions.

Career Highlights

Throughout his career, Marc Delcourt has worked with several notable companies. He has served as a scientist at Fortune, S.A. and Global Bioenergies. His expertise in biotechnology has allowed him to contribute to various projects aimed at improving enzyme efficiency and chemical production processes.

Collaborations

Delcourt has collaborated with esteemed colleagues, including Maria Anissimova and Philippe Marliere. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Marc Delcourt's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in sustainable chemical production.

Profile summary based on public USPTO records.